Who owns Verrica Pharmaceuticals Inc?
- Ticker: VRCA
- CUSIP Number: 92511w108
Tip: Access positions for across all investors
Analyze quarterly positions in Verrica Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Verrica Pharmaceuticals stock
Who bought or sold Verrica Pharmaceuticals Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Perceptive Advisors | 7.1M | $52M | 41% | Dec 2023 |
|
venBio Select Advisor | 4.0M | $29M | 35% | Dec 2023 |
|
Vanguard Group | 1.3M | $9.2M | 3% | Dec 2023 |
|
BML Capital Management | 180k | $1.1M | 0% | Mar 2024 |
|
Steel Peak Wealth Management | 138k | $817k | 0% | Mar 2024 |
|
Miracle Mile Advisors | 118k | $700k | 0% | Mar 2024 |
|
J. Goldman & Co | 108k | $791k | 100% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 86k | $626k | 74946% | Dec 2023 |
|
Kornitzer Capital Management | 74k | $440k | 0% | Mar 2024 |
|
Balyasny Asset Management | 65k | $478k | 100% | Dec 2023 |
|
Charles Schwab Investment Management | 55k | $328k | 0% | Mar 2024 |
|
Bank of New York Mellon | 54k | $321k | -3% | Mar 2024 |
|
Kovitz Investment Group Partners | 50k | $367k | 0% | Dec 2023 |
|
Bank of America Corporation | 37k | $269k | 2% | Dec 2023 |
|
SPC Financial | 30k | $178k | 0% | Mar 2024 |
|
Barclays | 29k | $210k | 689% | Dec 2023 |
|
UBS Group | 24k | $178k | 118% | Dec 2023 |
|
AQR Capital Management | 22k | $164k | 2% | Dec 2023 |
|
Rhumbline Advisers | 22k | $131k | -1% | Mar 2024 |
|
Stifel Financial | 21k | $150k | 0% | Dec 2023 |
|
Creative Planning | 19k | $139k | 0% | Dec 2023 |
|
Citadel Advisors | 19k | $138k | -35% | Dec 2023 |
|
Legacy Trust | 19k | $111k | 0% | Mar 2024 |
|
Jpmorgan Chase & Co | 14k | $100k | 0% | Dec 2023 |
|
Dimensional Fund Advisors | 12k | $69k | 0% | Mar 2024 |
|
Cambridge Investment Research Advisors | 12k | $68k | 100% | Mar 2024 |
|
Branch Banking & Trust Company | 11k | $77k | -34% | Dec 2023 |
|
American International | 10k | $76k | 0% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 10k | $61k | -74% | Mar 2024 |
|
Jane Street | 10k | $75k | 100% | Dec 2023 |
|
Two Sigma Securities | 10k | $74k | 100% | Dec 2023 |
|
New York State Common Retirement Fund | 9.8k | $58k | 8% | Mar 2024 |
|
Royal Bank of Canada | 8.8k | $64k | -8% | Dec 2023 |
|
Wells Fargo & Company | 7.7k | $46k | -22% | Mar 2024 |
|
Spire Wealth Management | 5.7k | $33k | 0% | Mar 2024 |
|
Citigroup | 3.8k | $23k | 28% | Mar 2024 |
|
Salomon & Ludwin | 2.9k | $17k | 0% | Mar 2024 |
|
Legal & General Group | 2.5k | $19k | 0% | Dec 2023 |
|
Simplex Trading | 2.3k | $13k | -49% | Mar 2024 |
|
Summit Investment Advisors | 1.7k | $13k | 0% | Dec 2023 |
|
Cetera Trust Company | 1.0k | $5.9k | 0% | Mar 2024 |
|
Amalgamated Bank | 704.00 | $4.0k | -76% | Mar 2024 |
|
Pnc Financial Services | 222.00 | $1.3k | 1750% | Mar 2024 |
|
Coppell Advisory Solutions | 200.00 | $1.5k | 0% | Dec 2023 |
|
Advisor Group Holdings | 100.00 | $732.000000 | 0% | Dec 2023 |
|
Russell Investments | 71.00 | $420.000500 | 0% | Mar 2024 |
|
Carmichael Hill & Associates | 21.00 | $125.000400 | 0% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 4.00 | $23.000000 | 100% | Mar 2024 |
|
CWM | 3.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Verrica Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Caligan Partners | Sep 2023 | 260k | $1.0M |
Boxer Capital | Sep 2023 | 167k | $649k |
Two Sigma Investments | Sep 2023 | 65k | $251k |
Mirae Asset Global Investments | Dec 2023 | 48k | $351k |
GSA Capital Partners | Dec 2023 | 39k | $282k |
Millennium Management | Sep 2023 | 28k | $110k |
Jump Financial | Sep 2023 | 18k | $71k |
Squarepoint Ops | Sep 2023 | 17k | $66k |
Goldman Sachs Group | Sep 2023 | 14k | $54k |
Susquehanna International | Sep 2023 | 13k | $49k |
Cutler | Dec 2023 | 2.5k | $0 |